Search Results 1851-1860 of 18222 for sickle cell
... Cell Lung Cancer. MC230818 Understanding the mechanisms of clonal and non-clonal cytopenia following CAR-T therapy (MC230818). Mankato, Minn., Rochester ...
... cells collected from healthy subjects. We will identify innate immune cell populations that contribute to astrocyte reactivity and elucidate the mechanisms ...
Radioactive drugs, such as lutetium Lu 177 dotatate, may carry radiation directly to tumor cells and may reduce harm to normal cells. Lutetium Lu 177 dotatate ...
... cell carcinoma, Solitary fibrous tumor, Undifferentiated pleomorphic sarcoma ... Rochester, MN. Areas of focus: Chemotherapy, CAR-T cell therapy, Lumbar ...
Mayo Clinic researchers use AI and genetics to identify early signs of a rare, life · Mayo Clinic researchers identify a new stem cell patch to gently heal ...
... cells for clinical trials through. Clinical Trials. FDA clears way for Mayo Clinic to accelerate production of stem cells for clinical trials through automation.
Preparing to biomanufacture a new CAR-T cell therapy for B-cell cancers featured. Research. Preparing to biomanufacture a new CAR-T cell therapy for B-cell ...
More Mayo neuroscience: Brain cells 'crosstalk' and cancer growth; Preoperative radiotherapy survival · Using a molecular scissors to improve CAR-T cell therapy ...
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!